Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1999
11/02/1999US5976832 DNA encoding novel calcium-binding proteins
11/02/1999US5976831 Therapeutic compounds, and more particularly to soluble and membrane-bound forms of a low-affinity receptor for human immunoglobulin g, nucleic acids encoding the same. diagnostic uses of such receptors.
11/02/1999US5976830 Methods of producing doxorubicin
11/02/1999US5976828 Identifying a gene product target of a biocidal drug.
11/02/1999US5976824 Method and apparatus for collecting a cell sample from a liquid specimen
11/02/1999US5976816 Cell tests for alzheimer's disease
11/02/1999US5976815 Screening drugs/ligands of activin receptor-like kinase 7 receptor by transfecting host cell with nucleic acid encoding receptor protein, contacting cell with drug/ligand, evaluating effect on kinase activity
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976808 Assays for identifying agents which affect regulators of UCP3 gene expression
11/02/1999US5976807 Eukaryotic cells stably expressing genes from multiple transfected episomes
11/02/1999US5976801 Human reticulocalbin isoforms
11/02/1999US5976798 Accurate diagnosis before or after symptoms by determining presence and frequency of missense mutations in mitochondrial cytochrome c oxidase gene, quantitating degree of heteroplasmy at mutation site, correlating with disease
11/02/1999US5976796 The gene product alone can be sufficient to allow detection of living cells under the light microscope.
11/02/1999US5976795 Retrotransposon and methods
11/02/1999US5976793 Methods of transcriptionally modulating gene expression and of discovering chemicals capable as gene expression modulators
11/02/1999US5976789 System of probes enabling HLA-DR typing to be performed, and typing method using said probes
11/02/1999US5976787 Possible sites for gene inactivation to attenuate mdv field isolates for vaccine purposes.
11/02/1999US5976572 Solid matrix, stabilizer, protein denaturing agent, free radical scavenger and detector
11/02/1999US5976567 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
11/02/1999US5976553 Transfection and genetic manipulations in obligate intracellular parasites
11/02/1999US5976546 Antigen presenting cells activated by contact with a polypeptide complex constructed by joining together a dendritic cell-binding protein and a polypeptide antigen.
11/02/1999US5976545 ZPC polypeptides
11/02/1999US5976544 Polypeptides and vaccines for Bordetellapertussis and method of use
11/02/1999US5976542 Bacterial enzymes as targets for antibiotic therapy and as bacterial vaccines.
11/02/1999US5976541 Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
11/02/1999US5976535 Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
11/02/1999US5976532 Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies or fragments thereof, including c7E3
11/02/1999US5976531 Composite antibodies of human subgroup IV light chain capable of binding to tag-72
11/02/1999US5976530 Peptide plasminogen activators
11/02/1999US5976528 Used to decrease the risk of chemical carcinogenesis comprising administering to a subject in need of such treatment an effective amount.
11/02/1999US5976338 DNA analyzer
11/02/1999US5974734 Solid matrix priming of seeds with microorganisms and selected chemical treatment
11/02/1999CA2171331C Synthesis of catechol from biomass-derived carbon sources
11/02/1999CA2150986C Oligonucleotide primers and probes for detection of bacteria
11/02/1999CA2144055C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
11/02/1999CA2119443C Human cyclin e
11/02/1999CA2066263C Tsh receptor
11/02/1999CA2053911C Recombinant antibody-toxin fusion protein
11/02/1999CA2002788C Adp glucose-pyrophosphorylase
11/02/1999CA1340813C Bacillus thuringiensis isolate denoted b.t. ps81f active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
11/02/1999CA1340812C Bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
11/02/1999CA1340806C Method, system and reagents for dna sequencing
10/1999
10/30/1999CA2775100A1 Method for giving resistance to weed control compounds to plants
10/30/1999CA2269221A1 Active hedgehog protein conjugate, process for its production and use
10/29/1999CA2269215A1 Genetic markers for rpsl-k gene and method of use
10/29/1999CA2230203A1 Delta ribozyme for rna cleavage
10/28/1999WO1999054738A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999WO1999054735A1 Improved immunodiagnostic assays using reducing agents
10/28/1999WO1999054732A1 IλB AND ENHANCED GREEN FLUORESCENT FUSION PROTEIN
10/28/1999WO1999054724A1 Process for evaluating chemical and biological assays
10/28/1999WO1999054707A2 Fetal testing for prediction of low birth weight
10/28/1999WO1999054510A2 Quantitative analysis of gene expression
10/28/1999WO1999054509A1 Methods for reducing non-specific binding to a nucleic acid probe array
10/28/1999WO1999054501A1 A method for the characterisation of nucleic acid molecules involving generation of extendible upstream dna fragments resulting from the cleavage of nucleic acid at an abasic site
10/28/1999WO1999054498A1 Method for detecting allelic imbalance
10/28/1999WO1999054493A2 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999WO1999054491A1 Use of murine myosin heavy chain promoters for gene therapy and production of transgenics
10/28/1999WO1999054490A2 Plant-derived resistance gene
10/28/1999WO1999054489A1 Stress tolerant plants
10/28/1999WO1999054488A1 Food-grade cloning vector and their use in lactic acid bacteria
10/28/1999WO1999054487A2 A method for isolating a polynucleotide of interest from the genome of a mycobacterium using a bac-based dna library. application to the detection of mycobacteria
10/28/1999WO1999054486A1 Canine erythropoietin gene and recombinant protein
10/28/1999WO1999054485A1 A method for inhibiting tumor invasion or spreading in a subject
10/28/1999WO1999054483A1 Gene of rice dihydrodipicolinate synthase and dna relating to the same
10/28/1999WO1999054482A1 Dna fragmentation factor involved in apoptosis
10/28/1999WO1999054481A1 Mutant having uracil phosphoribosyl transferase activity
10/28/1999WO1999054480A1 Transgenic plants presenting a modified inulin producing profile
10/28/1999WO1999054479A2 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES
10/28/1999WO1999054478A1 Gene encoding protein having aurone synthesizing activity
10/28/1999WO1999054477A2 Genetically engineered yeast and mutants thereof for the efficient fermentation of lignocellulose hydrolysates
10/28/1999WO1999054475A2 Identification of lactic acid bacterial genes involved in the biosynthesis of exopolysaccharides
10/28/1999WO1999054474A2 Bacterial yiha polypeptide family
10/28/1999WO1999054473A2 Bacterial yjeq polypeptide family
10/28/1999WO1999054472A1 Novel insecticidal toxins from xenorhabdus nematophilus and nucleic acid sequences coding therefor
10/28/1999WO1999054471A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata
10/28/1999WO1999054470A2 Bacterial ygjd polypeptide family
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054468A1 Soluble protein ztmpo-1
10/28/1999WO1999054467A1 Sh2 domain-containing peptides
10/28/1999WO1999054466A2 Colon cancer-associated antigens and their diagnostic and therapeutic uses
10/28/1999WO1999054465A2 Gene encoding syntaxin interacting protein
10/28/1999WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054462A2 Bacterial ycfb polypeptide family
10/28/1999WO1999054461A2 Human nucleic acid sequences of endometrium tumour tissue
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054459A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/28/1999WO1999054458A1 Use of a ribozyme to join nucleic acids and peptides
10/28/1999WO1999054457A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
10/28/1999WO1999054456A1 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF INTEGRIN αv-SUBUNIT EXPRESSION
10/28/1999WO1999054454A1 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors
10/28/1999WO1999054453A1 Novel genetically modified lactic acid bacteria having modified diacetyl reductase activities
10/28/1999WO1999054448A2 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
10/28/1999WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999WO1999054446A2 Human nucleic acid sequences which are overexpressed in normal pancreas tissue
10/28/1999WO1999054445A2 Combination therapy using nucleic acids and conventional drugs
10/28/1999WO1999054444A2 Combination therapy using nucleic acids and radio therapy
10/28/1999WO1999054443A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep
10/28/1999WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999WO1999054437A2 Novel molecules of the t125-related protein family and uses thereof
1 ... 3334 3335 3336 3337 3338 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 ... 4023